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Summary A method is presented in this report for concurrent analysis of vascular architecture, blood perfusion and proliferation
characteristics in whole-tumour cross-sections of human larynx carcinoma and glioblastoma xenografts. Tumours were implanted
subcutaneously in nude mice. After i.v. injection with Hoechst 33342 and bromodeoxyuridine (BrdUrd) as perfusion and proliferation markers,
animals were killed. An antiendothelial antibody (9F1) was used to delineate vascular structures. Cross-sections were analysed by a multistep
immune staining and a computer-controlled microscope scanning method. Each tumour section was stained and scanned four times
(Hoechst, 9F1, BrdUrd and Fast Blue for all nuclei). When these images were combined, vasculature, perfusion and proliferation parameters
were analysed. The labelling index (LI) was defined as the ratio of the BrdUrd-labelled area to the total nuclear area. The LI based on manual
counting and the LI calculated by flow cytometry (FCM) were in good agreement with the LI based on surface analysis. LI decreased at
increasing distance from its nearest vessel. In the vicinity of perfused vessels, the LI was 30-70% higher than near non-perfused vessels.
This method shows that both vasculature/perfusion and proliferation characteristics can be measured in the same whole-tumour section in a
semiautomatic way. This could be applied in clinical practice to identify combined human tumour characteristics that predict for a favourable
response to treatment modifications.
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The radiation response of tumours is determined by several well-
recognized factors, including intrinsic radio sensitivity, cell kinetics
and the degree of tumour oxygenation and perfusion. There is
increasing recognition that a combination of these mechanisms
may be responsible for treatment failure in certain tumour types.
The prognostic relevance ofintrinsic radio sensitivity, measured
by clonogenic assays, has been demonstrated for cancer of the
uterine cervix (Levine et al, 1995) and for head and neck cancer
(Girinsky et al, 1993).
Another cause for radiation treatment failure is tumour cell
repopulation, which compensates for radiation-induced cell kill.
The longer the overall treatment time of fractionated radiation
treatments, the greater the opportunity for tumour cell repopula-
tion. Withers et al (1988) have reviewed 59 clinical studies on
head and neck cancer and have demonstrated that the outcome was
worse with longer treatment schedules. Preliminary results from
four randomized studies in head and neck cancer and one in
bronchus carcinoma demonstrate that tumour control rates can be
improved with shortened radiation treatment schedules delivering
two or more radiation fractions per day relative to once-a-day
treatments with conventional radiotherapy (Ang et al, 1996;
Horiot et al, 1996; Overgaard et al, 1996; Saunders, 1996).
Begg et al (1990) measured the potential doubling time (T0t) in
biopsies of head and neck carcinomas by flow cytometry (FCM)
and showed that this could be predictive for treatment outcome.
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A trend was shown for the fast proliferating tumours to perform
worse on a conventional treatment schedule than slow proliferating
tumours. The outcome of the fast proliferating tumours was
improved with accelerated radiotherapy, although the differences
were not statistically significant. In data collected from ten
different European trials, Begg et al (1990) showed that the
pretreatment kinetic parameters, analysed by flow cytometry, can
predict local control after conventional radiotherapy (Denekamp
and Fowler, 1997). Bennett et al (1992) categorized squamous cell
carcinomas by histological proliferation patterns that appeared to
be correlated with radiation treatment outcome.
A third factordetermining the effect ofradiotherapy is oxygena-
tion. Radiotherapy is less effective under hypoxic conditions
(Gray et al, 1953; Minchinton et al, 1991). Hypoxia exists in
varying degrees in nearly all tumours. In advanced cancer of the
uterine cervix and in nodal metastases of head and neck tumours,
intratumoral pO2, as detected by polarographic measurements,
predicted for survival (Gatenby et al, 1988; Hockel et al, 1993;
Nordsmark et al, 1996).
A variety of procedures have been developed to overcome
hypoxic radiation resistance including high oxygen content gas
breathing under normo- or hyperbaric conditions, hypoxic cell
radiosensitizers, blood transfusions and use ofvasoactive drugs. A
meta-analysis of 83 randomized clinical trials showed that both
local control and survival can be improved by reduction of
hypoxia (Overgaard and Horsman, 1993).
Tumour hypoxia is the result ofa chaotically organized vascular
network and an insufficient and heterogeneous blood supply. A
detailed understanding of the vascular architecture and perfusion
status of tumours is necessary to develop and assess methods for
tumour oxygenation modification in an effort to improve radiation
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response. In addition, it has been shown that the metastatic poten-
tial of tumours is related to certain vascular parameters (Weidner
et al, 1993). The morphological aspects are commonly analysed
using stereological principles such as the point-counting method
(Chalkley et al, 1943; Fox et al, 1995). Information on vascular
function is obtained using radioactive and fluorescent perfusion
markers (Jain, 1988).
Bermsen et al (1995) presented a method to analyse quantita-
tively both morphological parameters of vascular architecture and
perfusion using an automated image analysis system. This paper
presents a further development of this method that includes the
simultaneous measurement ofkinetic parameters.
The aim of this study was to standardize a method for quantita-
tive analysis of vasculature, blood perfusion and proliferation in
the same tissue section. This could be applied in clinical practice
to identify the combined human tumour characteristics that predict
for a favourable response to treatment modifications, including
oxygen modification, altered fractionation schedules and combi-
nations ofthese approaches.
MATERIALS AND METHODS
Tumours
Tumours were derived from different primary human high-grade
gliomas and head and neck squamous cell carcinomas (moderately
to well-differentiated). Viable 1-mm3 tumour pieces were trans-
planted subcutaneously in nude mice (Balb/c nu/nu mouse).
Tumours were passaged when they reached a diameter of
1-1.5 cm. For the analysis of vascular and kinetic parameters,
tumours with a diameter of0.6-1.0 cm were used.
Markers of proliferation and perfusion
The S-phase marker bromodeoxyuridine (BrdUrd) (Sigma
Chemical, St Louis, MO, USA) was given at a dose of 100 mg kg'
intraperitoneally, 15 min before the animals were killed. In experi-
ments in which the in situ analysis is compared with flow cytom-
etry (FCM), BrdUrd was injected 5 h before killing the animals to
allow calculation of the potential doubling time (T t) by the rela-
tive movement method (Begg et al, 1985). Two minutes before
killing the animals, Hoechst 33342 was given intravenously via
one of the tail veins as a marker of perfusion. Tumour specimens
were cut in two: half was stored in liquid nitrogen until frozen
sections were cut, which were then stored at -80°C until staining
and the other half was fixed in 70% ethanol for FCM analysis.
Immunohistochemical staining
After thawing, sections of 5 gm thickness were fixed in acetone
for 10 min and slides were then rinsed and mounted in phosphate-
buffered saline (PBS). Then, the tissue sections were scanned for
the Hoechst signal. The starting point and the resulting composite
binary image with perfused tissue areas were both stored in the
computer. Details on the scanning procedure are given below.
The same sections were then stained for endothelial structures.
First, they were incubated for 45 min at room temperature
with undiluted 9F1 (rat monoclonal antibody to mouse endo-
thelium, Department of Pathology, University Hospital Nijmegen,
The Netherlands). After rinsing, the sections were then incubated
for 30 min at room temperature with tetramethylrhodamine
isothiocyanate (TRITC)-conjugated rabbit anti-rat antibodies
(Organon Teknick, West Chester, PA, USA) diluted 1:100 in phos-
phate-buffered saline (PBS) with 10% normal mouse serum
followed by rinsing and 30 min incubation at room temperature
with TRITC-conjugated goat anti-rabbit (Tago, Burlingame, CA,
USA) diluted 1:50 in PBS with 1% BSA. The sections were then
rinsed again.
Next, BrdUrd was immunohistochemically visualized. The
DNA of the tissue sections was denatured by incubation with 2 N
hydrochloric acid for 10 min. To neutralize the pH, sections were
rinsed in 0.1 M borax for 10 min followed by rinsing in PBS. The
sections were then incubated for 60 min at 37 °C with Br-3 (mouse
monoclonal to BrdUrd, Caltag Laboratories S. San Francisco, CA,
USA) diluted 1:50 in PBT (PBS with 1% BSA and 0.5% Tween-
20). Next, after rinsing with PBS again, the sections were
incubated for45 min at room temperature with fluorescein isothio-
cyanate (FITC)-conjugated rat anti-mouse antibodies (Dako,
Denmark) diluted 1:25 in PBT.
As a final step, all nuclei were stained with Fast Blue (Sigma)
diluted 1:1000 in PBS for 15 min at room temperature and finally
rinsed again.
Scanning of tumour sections and image processing
The tumour sections were scanned by a computer-controlled
procedure using a high-resolution intensified solid-state camera
for quantitative analysis on a Zeiss microscope. A detailed
description ofthis scanning method has been given by Rijken et al
(1995). Each tumour section was sequentially scanned four times,
at 200 x magnification, using different filters (TRITC signal,
510-560 nm excitation and 690 nm emission filter; FITC,
450-490 nm excitation and 520 nm emission filter; Hoechst and
Fast Blue, 365 nm excitation and 420 nm emission filter). After
processing all fields (scanning in eight times eight steps, i.e. 64
fields with a field size of 0.31 mm2), the scanned area was recon-
structed from the separate processed images into one large
composite image. The result of this scanning procedure is four
composite images: one showing the perfused areas (Hoechst), one
showing vascular structures (9F1), one showing proliferating
nuclei (BrdUrd) and one showing all nuclei (Fast Blue). As a final
step, the tumour area was determined by drawing a contour line.
This area was used as a mask in further image analysis, excluding
non-tumour tissue and necrotic areas from the analysis. Stromal
cells that are close to tumour cells or embedded in the tumour
tissue (for instance near vascular structures) cannot be excluded
from the analysis.
Analysis of vascular and kinetic parameters
The vascular parameters can be derived from the first two
composite images (Hoechst and 9F1) (Bernsen et al, 1995). When
these two images are combined, the overlapping structures repre-
sent those vascular structures that were perfused at the time of
injection of Hoechst; the vascular structures that have no corre-
sponding Hoechst staining of adjacent nuclei represent non-
perfused vessels. The area of perfused vascular structures divided
by the total vascular area of the tissue section yields the perfusion
fraction, indicating the fraction of vascular structures that was
perfused at the time of Hoechst injection.
Because ofthe high cellular density ofmost tumours in the tissue
sections, nuclei are often abutting or overlapping and individual
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Figure 1 The principle of vascular domains: the tissue section is divided
into areas on the basis of vascular structure, domains. The boundaries of
these domains are equidistant to adjacent vessels
nuclei cannot always be discriminated by the scanning system. It is
therefore not possible to calculate the labelling index (LI), which is
the number of BrdUrd-positive nuclei relative to the total number
of nuclei, based on the count of individual labelled and unlabelled
nuclei. Therefore, the LI was determined from the ratio of the
BrdUrd-positive surface (FITC) to the total nuclear surface (Fast
Blue). To validate this method, the same microscopic fields were
analysed by the computer-controlled analysis system and by
manual counting, both at 400 x magnification. With the manual
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Figure 3 LI after computerized in situ analysis vs FCM; the samples of the
aneuploid tumours are indicated by asterisks
count, at least 200 nuclei were counted in 15 microscope fields of a
glioblastoma tumour line. The LI obtained by the two methods
were compared.
The heterogeneity of distribution of proliferating cells within a
tumour section was assessed by dividing the composite image in
16 x 16 fields, thus yielding 256 arbitrary tissue areas of
0.076 mm2 each, corresponding to approximately one high-power
microscope field of 400 x magnification. For each of these indi-
vidual areas the LI was calculated and the mean LI ofthe 256 tissue
areas with standard deviation were obtained for each tissue section.
In addition, the overall LI for the whole section was calculated.
For a better understanding ofthe relationship between prolifera-
tion and vascularity, the composite images were subdivided into
functional units, so-called 'vascular domains'. A domain was
constructed around each vascular structure in a separate image.
The boundaries ofthese domains were defined such that they were
Figure 2 The process of staining and scanning of the same tissue section (squamous cell carcinoma tumour line PC3). Binary reconstructed image after
scanning a tissue section four times. Hoechst for perfusion (blue), 9F1 TRITC for vascular structures (red), BrdUrd FITC for proliferation (green). The Fast Blue
signal for the total nuclear surface is not shown. Note non-perfused vascular structures (solid arrow) and perfused vascular structures and the decrease in LI at
increasing distance from vessels
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equidistant to adjacent vessels (Figure 1). In the recorded
composite images, the LI was calculated in four arbitrary zones at
increasing distance from the surface of the vessel in each domain:
0-15 jm, 15-30 jim, 30-70 gm and > 70 jim from the nearest
vessel. The LI was analysed for every individual domain, distin-
guishing perfused and non-perfused domains.
Flow cytometry
The method of staining and analysis using flow cytometry (FCM)
has been described elsewhere (Bennett et al, 1992). Briefly,
ethanol-fixed tissue fragments were digested into nuclei using
0.4 mg ml-1 pepsin in 0.1 M hydrochloric acid for 30 min at 37 °C.
DNA was denatured with 2 M hydrochloric acid for 12 min at
room temperature. The nuclei were incubated with Br-3 FITC
conjugate (mouse monoclonal to BrdUrd, Caltag Laboratories) in
PBS containing 0.5% Tween-20 and 0.5% normal goat serum for
2 h at room temperature. Total DNA was stained using 10 jg ml-1
propidium iodide and the samples were analysed by FCM.
Samples were run on a Becton Dickinson FACScan with a single
excitation wavelength of 488 nm. Doublets were excluded by
gating on the width and area signals from the FL3 channel. Ten
thousand events were collected. The data derived from the FCM
profiles were the DNA index, the LI of all cells and of the aneu-
ploid subcompartment in appropriate tumours making a correction
for cell division (Wilson et al, 1995). The DNA synthesis time (Ts)
was calculated using the method of Begg et al (1985) and the T
was derived using the formula: T = Xx Ts/LI, with X =0.8. pot
Statistics
The LI obtained by the scanning method based on labelled surface
analysis was compared with the LI obtained by manual counting
and by FCM using linear least-squares regression analysis. The t-
test was used to compare LI in perfused domains with the LI in
non-perfused domains. For analysis of the decrease in LI at
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Figure 4 Li after computerized in situ analysis vs manual count
increasing distance from vascular structures, MANCOVA was
used for all data points. To determine where these differences in
the means ofany two distance intervals were present, the post-hoc
Tukey honest significant difference (HSD) test for multiple
comparisons was applied.
RESULTS
Images
Figure 2 shows the composite binary image obtained after the
scanning procedure for a representative tumour section. The
combination of the Hoechst, 9F1 and BrdUrd images clearly
shows the distribution of proliferating cells throughout the tissue
section and the relation to vascular structures (Figure 2). Note
perfused and non-perfused vascular structures and the decrease in
LI at increasing distance from vessels.
Table 1 FCM analysis vs computerized in situ analysis
Flow cytometry Computerized in situ analysis
Tumour Tpot (days)a Li all cells Li aneuplold cells Li in situb Meanc s.d.c Rangec
1 GM2 2.6 0.13 0.110 0.11 0.072 0-0.32
2 GM2 - - 0.059 0.033 0.032 0-0.16
3 GM34 7.0 0.041 0.064 0.05 0.040 0.034 0-0.17
4 GM34 - - 0.024 0.023 0.026 0-0.11
5 GM49 3.3 0.088 0.094 0.055 0.054 0.037 0-0.17
6 GM106 3.7 0.080 0.086 0.10 0.10 0.11 0-0.40
7 GM106 2.0 0.12 0.15 0.16 0.18 0.080 0-0.36
8 GM182 2.6 0.092 0.11 - - - -
9 GM192 8.9 0.034 0.038 0.027 0.029 0-0.14
10 PC3p3 - - 0.043 0.015 0.013 0-0.39
11 PC3p3 - - 0.016 0.013 0.015 0-0.059
12 PC20 5.2 0.046 0.054 0.050 0.032 0.031 0-0.12
13 PC18 - - - - - -
14 PC3p4 1.8 0.095 - - - -
15 PC3p4 8.3 0.033 0.063 0.060 0.049 0-0.21
16 PC3p4 5.6 0.056 0.075 0.073 0.0059 0-0.26
17 PC3p4 3.1 0.075 - - - -
18PC3p4 - - 0.037 0.023 0.027 0-0.094
GM, glioblastoma multiforme; PC, squamous cell carcinoma.aTp,t is calculated on the basis of the aneuploid cells if present, otherwise on the diploid cell
population. bOverall Li of a whole tissue section. cMean Li, standard deviation (SD) and range of 256 tissue areas of one tissue section.
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Figure 5 Example of the distribution of LI in 256 fields each representing
0.076 mm2 of a glioblastoma tissue section
BrdUrd LI: comparing three methods
Calculation of LI based on comIIputerized in situ analysis as the
ratio of BrdUrd-labelled nuclear surface to the total nuclear surface
was compared with manual counting and with FCM results.
For 12 tumours from seven different tumour lines, the LI obtained
by FCM was compared with the computerized in situ method. From
three samples it was not possible to obtain a reliable result by
computerized in situ analysis because ofheavy background staining
that made it impossible to analyse the tumour section. One tumour
consisted almost completely of necrosis and could not be analysed
by either computerized in situ analysis or FCM. In nine out of these
12 tumours both in situ and FCM results were available, showing a
good correlation between the two methods (correlation coefficient
0.81. Figure 3). Only six of these tumours were aneuploid: of these
six, the correlation with the computerized in situ analysis showed a
correlation coefficient of 0.90. Analysis by FCM also yielded T1>t
values, which are given in Table 1.
A good correlation was observed between the computerized
surface-based LI and the LI based on manual count (correlation
coefficient 0.89, P < 0.05, Figure 4).
Distribution of LI and relation to vasculature
Both the inter- and intratumour variability of LI are large (Table 1).
As an example of intratumour variability, the distribution profile
of the LI in a high-grade glioma is given in Figure 5 (number I in
Table 1).
After construction of the vascular domains, the LI was calcu-
lated at different distances from the surface of the nearest vessel.
Figure 6 shows the results obtained in three different squamous
cell carcinoma tumour lines. Each panel represents the average LI
of 4-5 tumours of the same tumour line. At increasing distance
from the nearest vessel, the LI decreases both in perfused and non-
perfused vascular domains. The LI calculated for the cells that are
nearest to the vessel is based on the area that also includes the
extravascular matrix. In this matrix, slower proliferating cells,
such as fibroblasts, are present, and this is the reason for the lower
LI in the 0-15 tm range. There is a statistically significant
decrease in LI at increasing distance in all three tumour lines with
P-values < 0.05 if the LI from 15-30 tm is compared with the
interval > 70( pm (Tukey HSD test).
Overall, the LI is lower in non-perfused domains than in
perfused domains (Figure 7).
Figure 6 LI vs distance from the nearest vessel, average of five tumours
with SEM. PC3, PC15 and PC19 are different human laryngeal squamous
cell carcinoma tumour lines
DISCUSSION
This paper describes how the semiautomatic method for quanitita-
tive analysis of tumour perfusion and vasculature, as described by
Rijken et al (1995), was further developed to allow also quantita-
tion of proliferative activity in the same tumour section. Without
disturbing tissue architecture, the proliferative patterns of tumours
can be studied and related to vascularity with the possibility oft
distinguishing between functional and non-functional vessels.
For detection of vascular structures the newly developed anti-
mouse endothelium antibody, 9FI, was used. It recognizes the
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Figure 7 Average Ll of four (PC19) or five (PC3 and PC15) tumours. Perfused domains (U) and non-perfused domains (3) at four different zones around
vessels. A, 0-15 ,um; B, 15-30 gm; C, 30-70 gm; and D, > 70 gm. Error bars indicate s.e.m. (*t-test, P < 0.05).
same vascular structures as the more commonly used collagen IV
antibody (HJJA Bernsen et al, submitted for publication). In the
squamous cell carcinoma xenografts, however, the collagen IV
antibody produces significant background staining because of
considerable amounts ofcollagen in the extracellular compartment
of these tumours. This background staining is less with the 9F1
antibody, which is therefore more suitable for the automated image
analysis.
The LI based on computerized surface analysis is in good agree-
ment with the LI based on manual counting and FCM analysis.
Other studies have also found a good correlation between LI based
on FCM and manual counting (Gasinska et al, 1989; Bennett et al,
1992; Bussink et al, 1995).
FCM has the advantage that large cell numbers can be counted.
However, this method produces an average LI for the entire tissue
sample and information on spatial heterogeneity of proliferative
activity within a tumour is lost. In addition, in diploid tumours
FCM cannot distinguish tumour cells from normal cells, which
may significantly influence the analysis. Assessment of LI by
computerized surface analysis gives a lower LI than manual
counting of labelled nuclei (difference approximately 0.05, Figure
3). This difference was also seen when the LI of tumour sections
was compared with the LI obtained by FCM (Bennett et al, 1992).
This difference could be caused by non-tumour cells in the
tumour section. Assessment of the LI by computerized surface
analysis can be influenced by the thresholding of the FITC signal.
If the threshold is set too high, BrdUrd-positive cells are not iden-
tified and will result in a lower LI. This can also introduce a
systemic difference between FCM measurements and our method.
Another advantage of the immunohistochemical method over
FCM is that it allows the study oftumourcell kinetics in relation to
histology. It has been suggested that the histological proliferation
pattern can be a stronger predictor for clinical outcome than the LI
or Tpo, (Bennett et al, 1992; Wilson et al, 1995). Manual counting
in tissue sections is time-consuming, however, and only limited
cell numbers can be analysed. In addition, there is an element of
subjectivity with interobserver variations. The computer-
controlled scanning method combines the strengths of FCM and
manual counting: proliferation patterns can be analysed rapidly in
complete tissue sections. In addition, the translation into binary
images greatly facilitates quantitation of any of the parameters
being studied (proliferation, vascular patterns and perfusion).
Two-dimensional analysis allows spatial study of relationships
between (functional) vessels and cell proliferation. Areas of
interest can be chosen for detailed analysis of non-tumour tissue
and necrotic areas can be easily excluded. FCM allows calculation
of T because it also gives information on the DNA content of
pot
nuclei (Begg et al, 1985). Calculation of T with the
immunohistochemical method would require two consecutive
injections with thymidine analogues, e.g. BrdUrd and IdUrd, to
allow estimation of S-phase duration (Asai et al, 1990). We have
attempted this, but with the computer analysis system double-
labelled nuclei are not always reliably distinguished from single-
labelled nuclei and technical improvements are required to enable
estimation of Tpo, by this method. In contrast, there is currently
some debate as to whether T has any additional value over LI as pot
a predictor of radiotherapy outcome. In data collected from ten
different European trials, Begg et al (1990) showed that both the
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LI and the T correlate with local control, but the LI is the pot
strongest predictor (Denekamp and Fowler, 1997).
The analysis of tumour cell proliferation in relation to the
nearest vessel and its perfusion status shows a decrease in LI with
increasing distance from the vessel. This was also noted in other
studies (Hirst et al, 1979; Rodriguez et al, 1994; Khali, 1996). One
might argue that this could be an artefact because BrdUrd, the
proliferation indicator, is transported to the tissues by the blood-
stream and a decrease in labelling away from the vessels might
simply reflect a limited diffusion capacity of the compound.
However, although decreased, we do observe labelled nuclei at a
greater distance from the vessels and dosage of the compound is
such that cellular uptake cannot be a limiting factor. In addition,
we have also analysed the proliferation patterns with the MIB-1
antibody, which binds to nuclear associated antigens that are natu-
rally present only in proliferating cells, and found similar results
(data not shown). The most plausible explanation for this phenom-
enon is that the availability of oxygen and nutrients decreases at a
greater distance from the vessels. The observation that the LI is
lower in non-perfused domains is in agreement with this.
However, the LI close to non-perfused vessels is still significantly
higher than the LI at a greater distance from perfused vessels.
Because both BrdUrd and Hoechst 33342 are bound in the DNA
by replacement of nucleotides, one could argue that the signal of
BrdUrd might quench the Hoechst signal. The half-life of BrdUrd
is relatively short (minutes). BrdUrd is only incorporated in the
DNA of S-phase cells. Hoechst-33342 will be visible in all nuclei
surrounding perfused vessels. If any disturbance of the Hoechst
signal by BrdUrd incorporation were to occur, this would only be
in a minority of cells (S-phase). As an example, Figure 2 shows
that the LI is higher near perfused than non-perfused vessels (the
arrow in Figure 2 indicates an area with no perfusion and a low LI).
It has been shown (Jain, 1988; Trotter et al, 1989) that tumour
blood vessels transiently open and close in a non-physiological
pattern. Vessels that are observed as non-functioning at a certain
time may be functional at some other time. This has been demon-
strated with the use of two different fluorescent perfusion markers
injected at different times (Trotter et al, 1989). These fluctuations
in tumour blood perfusion may explain why there is considerable
proliferative activity around apparently closed blood vessels. An
alternative explanation is that the 'non-perfused' domains are
supplied by nearby vessels that are locatedjust above or below the
plane ofthe tissue section being studied. Obviously, a limitation of
our image analysis system is that it allows only a two-dimensional
study. The technique does allow construction of a three-dimen-
sional image by simply scanning several consecutive slides of the
same tumour. However, this is laborious and it requires a powerful
computer and further development ofthe software.
In a future study, we will address the issue of the potential
sampling error. This is ofrelevance when the method is taken into
the clinic, because only relatively small biopsies can be obtained
from most cancer patients. Haustermans et al (1994) showed that
for oesophageal cancer increasing the number ofbiopsies from one
to five allowed better discrimination between slower and faster
proliferating tumours.
A future aim of our study is to incorporate a further step in the
analysis to directly indicate hypoxic areas in tumour sections. The
use of Hoechst as a perfusion marker is an indirect measure for the
oxygenation status. Hypoxic cells can be identified directly by biore-
ductive chemical probes, bound markers with immuno- recognizable
side-chains, e.g. 7-(4'-(2-nitroimidazole- 1-yl)-butyl)-theophylline
(NITP) (Webster et al, 1995). The metabolism of these compounds
involves the generation of a free radical that is so reactive towards
oxygen that further metabolism is inhibited in well-oxygenated cells.
The ultimate goal is to design an assay that can be helpful in
selecting patients or patient categories that can benefit from novel
radiotherapy treatments including altered fractionation schedules,
oxygenation modification orhypoxia-specific toxins (Kjellen et al,
1991; Horsman and Overgaard, 1992; Rojas et al, 1992; Brown
and Giaccia, 1994; Kaanders et al, 1995).
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